Rekombinanter Rituximab Antikörper

Produktnummer ABIN7482277

Produktdetails anti-Rituximab Antikörper

Target: Rituximab

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Rituximab Antikörper ist unkonjugiert

Applikation: ELISA, Lateral Flow (LF)

Verwendungszweck: Anti-Rituximab Antibody (MALS verified)

Produktmerkmale: Anti-idiotypic Antibodies

Güteklasse: MALS verified

Immunogen: Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).

Anwendungsinformationen

Applikationshinweise: This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Lagerung: -20 °C

Details zu Rituximab

Target: Rituximab

Abstract: Rituximab Produkte

Substanzklasse: Antibody

Hintergrund: Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.